Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JZP-507 commercial-scale vs pilot oral solution relative bioavailability study
NL-OMON44398Phase 1Active, not recruiting
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sodium oxybate in narcolepsy, sponsored by Jazz Pharmaceuticals plc. Started Jul 2017; status: active, not recruiting.
02
Drugs
sodium oxybate
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NL-OMON44398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44398.